Cathay Biotech Inc. (SHA:688065)

China flag China · Delayed Price · Currency is CNY
54.13
+0.20 (0.37%)
Apr 22, 2025, 10:45 AM CST
34.92%
Market Cap 31.75B
Revenue (ttm) 2.96B
Net Income (ttm) 486.73M
Shares Out 581.32M
EPS (ttm) 0.84
PE Ratio 65.01
Forward PE n/a
Dividend 0.19 (0.35%)
Ex-Dividend Date Jul 24, 2024
Volume 1,278,775
Average Volume 4,497,467
Open 54.57
Previous Close 53.93
Day's Range 53.75 - 54.75
52-Week Range 32.48 - 56.98
Beta 0.66
RSI 65.83
Earnings Date Apr 3, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In... [Read more]

Industry Chemicals
Sector Materials
Founded 2000
Employees 1,803
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688065
Full Company Profile

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.84% compared to the previous year's 2.11 billion. Earnings were 486.73 million, an increase of 32.80%.

Financial Statements

News

There is no news available yet.